Stop TB Partnership

The Medicines Patent Pool Posts Independent Feasibility Studies on Hepatitis C and Tuberculosis


06 July 2015 - The Medicines Patent Pool (MPP) posted two independent studies today as part of its ongoing consultation process on the possibility of expanding into other disease areas. The feasibility studies explore the case for potential entry into hepatitis C and tuberculosis.

MPP commissioned Dalberg and the Center for Disease Analysis for the study on hepatitis C, and Trinity Partners and Elizabeth Gardiner to conduct the analysis for tuberculosis. The consultants were tasked with providing their own strategic assessment of whether and to what extent MPP's model could be adapted to increase access to new and re-purposed products and promote innovation in these areas. MPP welcomes feedback from all stakeholders. Please send your comments on the reports or any other questions you might feel appropriate to consultation@medicinespatentpool.org by August 28.

To read the feasibility studies click here:

Feasibility study - MPP intervention in Hep C by Dalberg and CDA : http://www.medicinespatentpool.org/wp-content/uploads/MPP-Intervention-in-Hep-C_Dalberg_CDA.pdf

Feasibility study - MPP intervention in Tuberculosis by Trinity Partners: http://www.medicinespatentpool.org/wp-content/uploads/MPP-Intervention-in-TB-Trinity-Partners-.pdf